Last updated 2026-08-21
Total raised
—
Stage
—
Founded
2020
Headcount
—
HQ
Tel Aviv, Israel
Sector
Healthtech
About
NewMed Scientific Ltd. is an Israeli high-tech company established in 2020, focusing on medical devices. Their primary product, Localysis™, is a non-invasive bedside procedure designed to deliver thrombolytic drugs directly to the pulmonary arterial tree for the treatment of Pulmonary Embolism. This approach aims to reduce the risk of bleeding and make thrombolytic therapy more accessible to patients.
Q&A
- What is NewMed Scientific Ltd.'s primary product?
- NewMed Scientific Ltd.'s primary product is Localysis™, a treatment device for Pulmonary Embolism.
- When was NewMed Scientific Ltd. established?
- NewMed Scientific Ltd. was established in 2020.
- What is the core function of Localysis™?
- Localysis™ is a non-invasive bedside procedure designed to deliver thrombolytic drugs directly to the pulmonary arterial tree for the treatment of Pulmonary Embolism.
- What is the intended benefit of NewMed Scientific Ltd.'s Localysis™ approach?
- The Localysis™ approach aims to reduce the risk of bleeding and make thrombolytic therapy more accessible to patients suffering from Pulmonary Embolism.
- Who is the CEO and Founder of NewMed Scientific Ltd.?
- Dr. Avi Penner is the CEO and Founder of NewMed Scientific Ltd.
- In which sector does NewMed Scientific Ltd. primarily operate?
- NewMed Scientific Ltd. primarily operates in the Healthtech sector.
- Where is NewMed Scientific Ltd. headquartered?
- NewMed Scientific Ltd. is headquartered in Tel Aviv, Israel.
Team · 1
Dr. Avi Penner
Founder · CEO & Founder
Sectors & technology
Primary sector
Healthtech
Target customers
Business model
B2C
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | newmedsci.com |
|---|
Identifiers & details
| Founded | 2020 |
|---|